Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML. Damaskou A, Wilson R, Gozdecka M, Giotopoulos G, et al. Blood 2025;146:1239-1252.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Damaskou A, Wilson R, Gozdecka M, Giotopoulos G, et al. Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML. Blood 2025;146:1239-1252.
PMID: 40561247